MapmyGenome unveils study on genetic variants linked to longevity in long-living Indians

IMT News Desk
IMT News Desk
· 3 min read
dna molecular testing

The study analysed data from GenomegaDB, the most extensive genetic database of Indians, focusing on individuals aged 85 years and older

MapmyGenome has published its latest research in NPJ Aging (Nature.com). The study, ‘Genetic Variants Associated with Longevity in Long-Living Indians,’ explores the genetic factors contributing to healthy ageing and long life spans in the Indian population.

The study analysed data from GenomegaDB, the most extensive genetic database of Indians, focusing on individuals aged 85 years and older, referred to as Long Living Individuals (LLIs). By comparing LLIs with younger controls (18-49 years), researchers uncovered key genetic variants contributing to ageing longevity, and resistance to various diseases.

Key findings from the study

Genetic Defenses Against Diseases:

Variants linked to slower heart rate (MYH6), reduced risk of osteoporosis and shorter body height (ESR1), and decreased risks of schizophrenia (RIMS1-KCNQ5) and anxiety (HSPA5) were notably more frequent in LLIs.

Conversely, variants associated with increased risk of atrial fibrillation (GORAB-PRRX1) and biliary disorders (ABCC2) were less frequent in this group.

International Connection:

The study confirmed the significance of the FOXO3A gene, a well-known marker for longevity in Japanese, German, and French centenarians, in the Indian population as well.

Pathways Driving Longevity:

The findings highlight the role of genes involved in oxidative stress, DNA repair, apoptosis, glucose metabolism, and energy regulation, all of which play a crucial role in promoting healthy ageing.

“This research represents a monumental step forward in unravelling the genetic code of longevity,” said Anuradha Acharya, Founder and CEO, MapmyGenome. “Our findings not only reveal the genetic underpinnings of long life in Indians but also provide valuable insights into the biological mechanisms that promote healthy ageing.”

By identifying genetic variants unique to Indian LLIs, the study adds a critical dimension to global ageing research. It emphasises the diversity in genetic factors influencing longevity and underscores the importance of population-specific studies in understanding the broader genetic landscape.

Implications for personalised health and ageing

For consumers, this study has profound implications. It highlights the potential of genetic testing in helping individuals understand their predisposition to age-related diseases and develop personalised strategies for healthy ageing.

Proactive Health Management:

Insights into protective and risk-associated genetic variants can empower individuals to take preventive measures against conditions like cardiovascular diseases, osteoporosis, and anxiety.

Tailored Wellness Plans:

Genetic insights enable healthcare professionals to design targeted interventions, including lifestyle changes, dietary recommendations, and therapies, to optimise ageing outcomes.

Global Relevance:

By validating the role of genes like FOXO3A, this research bridges Indian and global longevity studies, highlighting common genetic threads while acknowledging unique regional variations.

“Our mission is to transform lives through genetics,” said Acharya. “This research reinforces our commitment to advancing scientific knowledge and empowering individuals with actionable insights for a healthier future.”

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk